Juncture Wealth Strategies’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
Juncture Wealth Strategies's GILD Position: Q2 2026 in Review
Juncture Wealth Strategies reduced its Gilead Sciences (GILD) stake by 4.4% in Q2 2026, selling an estimated $26.2K and leaving 4,340 shares worth $548K. The position accounts for 0.14% of the portfolio, ranked #107.
Juncture Wealth Strategies first reported a position in GILD in Q1 2019 and has held it in 11 quarters since. The position peaked at $955K in Q1 2025. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Juncture Wealth Strategies held 4,340 shares of Gilead Sciences worth $548K as of Q2 2026.
- Juncture Wealth Strategies sold 199 Gilead Sciences shares in Q2 2026, an estimated $26.2K.
- Gilead Sciences made up 0.14% of Juncture Wealth Strategies's portfolio in Q2 2026, its #107 holding.
- Juncture Wealth Strategies first reported a position in Gilead Sciences in Q1 2019 and has held it in 11 quarters since.
- Juncture Wealth Strategies's Gilead Sciences position peaked at $955K in Q1 2025.
- 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Juncture Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.